TY - JOUR
T1 - Ameliorative effect of Withania coagulans on dyslipidemia and oxidative stress in nicotinamide-streptozotocin induced diabetes mellitus
AU - Shukla, Kirtikar
AU - Dikshit, Piyush
AU - Tyagi, Mool Kumar
AU - Shukla, Rimi
AU - Gambhir, Jasvinder K.
N1 - Funding Information:
The authors are grateful to Indian Council of Medical Research, Delhi, India for providing financial assistance for this study (Ref.: PI. Jasvinder K. Gambhir, 59/33/2005/BMS/TRM).
PY - 2012/10
Y1 - 2012/10
N2 - Present study aims to evaluate the effect of Withania coagulans fruit (aqWC) on diabetic-dyslipidemia and antioxidant/oxidant status in DM. Diabetic animals were treated with aqWC at a dose of 250. mg/kg bw for 30. days. Lipid profile, MDA, GSH, SOD, FRAP, HMG CoA reductase and acetyl CoA carboxylase activities were estimated in blood and tissues. Total cholesterol, TAG and LDL were significantly elevated whereas HDL was decreased in diabetic animals (p<0.05), simultaneously the lipid content and HMG CoA reductase activities were also increased, whereas acetyl CoA carboxylase activity decreased significantly in tissues of diabetic animals. MDA was increased and antioxidants such as SOD, GSH and FRAP decreased significantly in DM (p<0.05). Oral administration of aqWC to diabetic animals produced significant improvement in serum lipid profile and tissue lipid content. Activity of HMG CoA reductase decreased, whereas acetyl CoA carboxylase activity increased significantly in tissues after aqWC treatment. Administration of aqWC to diabetic animals also showed significant increase in antioxidant levels i.e., GSH, SOD, FRAP and reduced level of MDA in blood and tissue homogenates as compared to diabetic controls (p<0.05). These results suggest that aqWC treatment improved lipid profile and decreased oxidative stress in diabetes mellitus.
AB - Present study aims to evaluate the effect of Withania coagulans fruit (aqWC) on diabetic-dyslipidemia and antioxidant/oxidant status in DM. Diabetic animals were treated with aqWC at a dose of 250. mg/kg bw for 30. days. Lipid profile, MDA, GSH, SOD, FRAP, HMG CoA reductase and acetyl CoA carboxylase activities were estimated in blood and tissues. Total cholesterol, TAG and LDL were significantly elevated whereas HDL was decreased in diabetic animals (p<0.05), simultaneously the lipid content and HMG CoA reductase activities were also increased, whereas acetyl CoA carboxylase activity decreased significantly in tissues of diabetic animals. MDA was increased and antioxidants such as SOD, GSH and FRAP decreased significantly in DM (p<0.05). Oral administration of aqWC to diabetic animals produced significant improvement in serum lipid profile and tissue lipid content. Activity of HMG CoA reductase decreased, whereas acetyl CoA carboxylase activity increased significantly in tissues after aqWC treatment. Administration of aqWC to diabetic animals also showed significant increase in antioxidant levels i.e., GSH, SOD, FRAP and reduced level of MDA in blood and tissue homogenates as compared to diabetic controls (p<0.05). These results suggest that aqWC treatment improved lipid profile and decreased oxidative stress in diabetes mellitus.
KW - Antioxidants
KW - Dyslipidemia
KW - Free radicals
KW - Lipid homeostasis
KW - Nicotinamide-streptozotocin induced diabetes mellitus
KW - Oxidative stress
UR - http://www.scopus.com/inward/record.url?scp=84865454573&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84865454573&partnerID=8YFLogxK
U2 - 10.1016/j.fct.2012.07.026
DO - 10.1016/j.fct.2012.07.026
M3 - Article
C2 - 22842119
AN - SCOPUS:84865454573
SN - 0278-6915
VL - 50
SP - 3595
EP - 3599
JO - Food and Chemical Toxicology
JF - Food and Chemical Toxicology
IS - 10
ER -